<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>An overview of angioedema: Pathogenesis and causes</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">An overview of angioedema: Pathogenesis and causes</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">An overview of angioedema: Pathogenesis and causes</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Bruce Zuraw, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Sarbjit Saini, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Anna M Feldweg, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jun 29, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Angioedema is self-limited, localized swelling of the skin or mucosal tissues, which results from extravasation of fluid into the interstitium due to a loss of vascular integrity. Angioedema may occur in isolation, accompanied by urticaria, or as a component of anaphylaxis.</p><p>The pathogenesis and causes of angioedema will be reviewed here. The clinical features, diagnosis, differential diagnosis, and management of acute angioedema are discussed separately. (See  <a class="medical medical_review" href="/d/html/8105.html" rel="external">"An overview of angioedema: Clinical features, diagnosis, and management"</a>.)</p><p class="headingAnchor" id="H2"><span class="h1">EPIDEMIOLOGY</span><span class="headingEndMark"> — </span>Data regarding the epidemiology of angioedema are limited, although it affects both adults and children and is not a rare disorder. In a retrospective review of all hospital admissions in New York State over 13 years, angioedema was the second most common "allergic" disease to necessitate hospitalization, exceeded only by asthma [<a href="#rid1">1</a>]. In this study, the number of angioedema hospitalizations per year more than doubled during the study period, suggesting that the prevalence may be increasing.</p><p>African Americans were disproportionately affected as they accounted for 42 percent of the admissions for angioedema but only 16 percent of the state's population.</p><p>The epidemiology of specific forms of angioedema, such as hereditary angioedema (HAE) due to C1 inhibitor (C1INH) deficiency, is discussed separately. (See  <a class="medical medical_review" href="/d/html/8103.html" rel="external">"Hereditary angioedema: Epidemiology, clinical manifestations, exacerbating factors, and prognosis"</a>.)</p><p class="headingAnchor" id="H3"><span class="h1">PATHOGENESIS</span><span class="headingEndMark"> — </span>Angioedema results from a loss of vascular integrity that allows fluid to move into tissues. Exposure of the vasculature to inflammatory mediators causes dilation and increased permeability of capillaries and venules. Fluid collects asymmetrically in the areas in which the vasculature has been altered, and these areas (eg, face, larynx, bowel wall) are <strong>not</strong> typically gravitationally dependent. Angioedema differs from the edema associated with cardiovascular, kidney, and liver disease (eg, heart failure, kidney failure, venous obstruction). Edema is usually due to an alteration in Starling's forces, such as an increase in intracapillary pressure or a reduction in the plasma oncotic pressure (ie, any cause of severe hypoalbuminemia) in the presence of normal vasculature. Edema affects gravitationally dependent parts of the body, and fluid collects symmetrically in those areas. (See  <a class="medical medical_review" href="/d/html/2309.html" rel="external">"Pathophysiology and etiology of edema in adults"</a>.)</p><p class="headingAnchor" id="H4"><span class="h1">CAUSES</span><span class="headingEndMark"> — </span>The known causes of angioedema can be subdivided into three groups, depending on the underlying mechanism  (<a class="graphic graphic_table graphicRef97087" href="/d/graphic/97087.html" rel="external">table 1</a>):</p><p class="bulletIndent1"><span class="glyph">●</span>Mast cell-mediated etiologies, in which angioedema results from release of mast cell-derived mediators that increase vascular permeability. Mast cell-mediated angioedema is associated with urticaria and/or pruritus in most cases.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Bradykinin-mediated etiologies, in which angioedema results from the generation of bradykinin, leads to increased vascular permeability. These forms of angioedema are <strong>not</strong> associated with urticaria and/or pruritus and are diagnosed and treated differently from other types of angioedema. (See  <a class="medical medical_review" href="/d/html/8105.html" rel="external">"An overview of angioedema: Clinical features, diagnosis, and management"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Etiologies of unknown mechanism.</p><p></p><p class="headingAnchor" id="H5"><span class="h2">Mast cell-mediated etiologies</span><span class="headingEndMark"> — </span>Mast cell-mediated angioedema is associated with urticaria and/or pruritus in many instances. This form of angioedema is pathologically similar to urticaria, although it takes place in the deeper levels of the dermis and subcutaneous tissues, most often involving the face or mouth. Mast cells can be activated via several mechanisms  (<a class="graphic graphic_table graphicRef58834" href="/d/graphic/58834.html" rel="external">table 2</a>). Activated mast cells release inflammatory mediators, including histamine, heparin, leukotriene C<sub>4</sub>, and prostaglandin D<sub>2</sub>, which cause dilation of venules in the dermis and enhance venule permeability with resultant tissue edema. (See  <a class="medical medical_review" href="/d/html/3979.html" rel="external">"Mast cells: Development, identification, and physiologic roles"</a> and  <a class="medical medical_review" href="/d/html/3981.html" rel="external">"Mast cells: Surface receptors and signal transduction"</a> and  <a class="medical medical_review" href="/d/html/3972.html" rel="external">"Mast cell-derived mediators"</a>.)</p><p>Acute mast cell-mediated angioedema is treated with antihistamines and with <a class="drug drug_general" data-topicid="9409" href="/d/drug information/9409.html" rel="external">epinephrine</a>, if severe and accompanied by symptoms in other organ systems beyond the skin. The treatment of mast cell-mediated angioedema is discussed in detail separately. (See  <a class="medical medical_review" href="/d/html/8105.html" rel="external">"An overview of angioedema: Clinical features, diagnosis, and management"</a>.)</p><p class="headingAnchor" id="H6"><span class="h3">Allergic reactions</span><span class="headingEndMark"> — </span>Acute angioedema, with or without other symptoms of allergic reactions, may be triggered by foods, drugs, latex, exercise, the stings of various insects, and a growing list of other uncommon allergens  (<a class="graphic graphic_table graphicRef70667" href="/d/graphic/70667.html" rel="external">table 3</a>). Angioedema is a common component of anaphylaxis, and, since anaphylaxis is treated differently from isolated angioedema (ie, with <a class="drug drug_general" data-topicid="9409" href="/d/drug information/9409.html" rel="external">epinephrine</a>), the clinician must be vigilant for other signs and symptoms of anaphylaxis (such as urticaria, pruritus, flushing, throat tightness, bronchospasm, and hypotension) in patients presenting with angioedema.</p><p>The classic type of allergic reaction results from immunoglobulin E (IgE) mediated, Gell and Coombs type I hypersensitivity  (<a class="graphic graphic_table graphicRef80466" href="/d/graphic/80466.html" rel="external">table 4</a>). The reaction typically occurs within minutes to two hours following exposure to the trigger. However, some IgE-mediated allergic reactions are delayed in onset, such as allergic reactions to certain meats (lamb, beef, and/or pork) that can lead to reactions with prominent angioedema beginning two to six hours after ingestion [<a href="#rid2">2</a>]. (See  <a class="medical medical_review" href="/d/html/106778.html" rel="external">"Anaphylaxis: Acute diagnosis"</a> and  <a class="medical medical_review" href="/d/html/2401.html" rel="external">"Food-induced anaphylaxis"</a> and  <a class="medical medical_review" href="/d/html/2393.html" rel="external">"Allergy to meats"</a>.)</p><p>Isolated angioedema is a relatively uncommon presentation of an allergic reaction. In a series of 112 patients with penicillin allergy confirmed by skin testing, only 1 patient had experienced isolated angioedema without urticaria during the presenting allergic reaction [<a href="#rid3">3</a>]. However, it can occur. Examples include reactions to nonsteroidal antiinflammatory drugs (NSAIDs). (See <a class="local">'Aspirin and NSAIDs'</a> below.)</p><p class="headingAnchor" id="H7"><span class="h3">Direct mast cell release</span><span class="headingEndMark"> — </span>Mast cells can be nonspecifically stimulated to release their proinflammatory mediators by certain medications and pharmaceuticals, such as opiates and radiocontrast media. This type of angioedema is accompanied by urticaria in most cases. IgE is not involved, and skin testing or in vitro testing is rarely helpful. (See  <a class="medical medical_review" href="/d/html/2075.html" rel="external">"Diagnosis and treatment of an acute reaction to a radiologic contrast agent"</a>.)</p><p class="headingAnchor" id="H8"><span class="h3">Aspirin and NSAIDs</span><span class="headingEndMark"> — </span>Nonsteroidal antiinflammatory drugs (NSAIDs), such as <a class="drug drug_general" data-topicid="8907" href="/d/drug information/8907.html" rel="external">aspirin</a> and <a class="drug drug_general" data-topicid="8547" href="/d/drug information/8547.html" rel="external">ibuprofen</a>, can cause acute urticaria/angioedema and can exacerbate chronic urticaria/angioedema. There are six known types of hypersensitivity reactions to NSAIDs, which are often difficult to distinguish from one another based on clinical history alone  (<a class="graphic graphic_table graphicRef90304" href="/d/graphic/90304.html" rel="external">table 5</a>). (See <a class="local">'Chronic urticaria with or without angioedema'</a> below and  <a class="medical medical_review" href="/d/html/2082.html" rel="external">"NSAIDs (including aspirin): Allergic and pseudoallergic reactions"</a>.)</p><p>The more common type of NSAID reaction is believed to be due to the pharmacologic properties of the medications on mast cells. NSAIDs inhibit the enzyme cyclooxygenase 1 (COX-1), which mediates the generation of prostaglandins from arachidonic acid within mast cells and other leukocytes. NSAID administration results in increased formation of proinflammatory mediators, leading to angioedema in susceptible individuals. NSAIDs that nonselectively inhibit both COX-1 and COX-2 enzymes (<a class="drug drug_general" data-topicid="8907" href="/d/drug information/8907.html" rel="external">aspirin</a>, <a class="drug drug_general" data-topicid="8547" href="/d/drug information/8547.html" rel="external">ibuprofen</a>, and most others) can potentially induce this effect, and patients often react to multiple agents. Selective COX-2 inhibitors, such as <a class="drug drug_general" data-topicid="8847" href="/d/drug information/8847.html" rel="external">celecoxib</a>, are tolerated by most patients who have reacted to nonselective NSAIDs [<a href="#rid4">4</a>], although rare exceptions are reported [<a href="#rid5">5</a>]. Management of patients with these reactions is reviewed separately. (See  <a class="medical medical_review" href="/d/html/2082.html" rel="external">"NSAIDs (including aspirin): Allergic and pseudoallergic reactions", section on 'Types 1 to 4: Treatment options'</a>.)</p><p>NSAIDs can also cause rare IgE-mediated allergic reactions, which are typically triggered by a single agent. The diagnostic approach to NSAID reactions is reviewed separately. (See  <a class="medical medical_review" href="/d/html/2082.html" rel="external">"NSAIDs (including aspirin): Allergic and pseudoallergic reactions"</a>.)</p><p class="headingAnchor" id="H9"><span class="h3">Chronic urticaria with or without angioedema</span><span class="headingEndMark"> — </span>Chronic urticaria refers to urticaria that continues to recur for a period of six weeks or longer [<a href="#rid6">6</a>]. Angioedema is present in at least one-half of patients with chronic urticaria [<a href="#rid7">7</a>].</p><p>Chronic urticaria may persist over months to years and is more common in females, particularly between the ages of 40 and 50 years. In most cases of chronic urticaria/angioedema, a specific cause cannot be identified. This disorder is reviewed in more detail separately. (See  <a class="medical medical_review" href="/d/html/8108.html" rel="external">"Chronic spontaneous urticaria: Clinical manifestations, diagnosis, pathogenesis, and natural history"</a> and  <a class="medical medical_review" href="/d/html/8106.html" rel="external">"Chronic spontaneous urticaria: Standard management and patient education"</a>.)</p><p class="headingAnchor" id="H10"><span class="h2">Bradykinin-mediated etiologies</span><span class="headingEndMark"> — </span>Angioedema can occur due to vasodilation and increased vascular permeability resulting from other inflammatory mediators, especially bradykinin. Angioedema can result from either overproduction of bradykinin or inhibition of bradykinin degradation. Mast cells are not believed to be involved in this form of angioedema, and <strong>pruritus and urticaria are</strong> <strong>absent</strong>. Bradykinin-mediated angioedema, unlike histamine-mediated angioedema, frequently affects the gastrointestinal mucosa, leading to bowel wall edema and presenting with episodes of abdominal pain, nausea, vomiting, and/or diarrhea.</p><p>Perturbations in kinin pathways resulting directly from the actions of medications (eg, angiotensin-converting enzyme [ACE] inhibitors) or from deficiencies of C1 inhibitor (C1INH) are the main recognized causes of bradykinin-mediated angioedema. The treatment of bradykinin-induced angioedema is discussed separately. (See  <a class="medical medical_review" href="/d/html/8105.html" rel="external">"An overview of angioedema: Clinical features, diagnosis, and management"</a>.)</p><p>Bradykinin-mediated angioedema does not respond to <a class="drug drug_general" data-topicid="9409" href="/d/drug information/9409.html" rel="external">epinephrine</a>, antihistamines, or glucocorticoids. Instead, this type of angioedema is treated with drugs that act on the bradykinin pathway (eg, <a class="drug drug_general" data-topicid="16808" href="/d/drug information/16808.html" rel="external">icatibant</a>, <a class="drug drug_general" data-topicid="9035" href="/d/drug information/9035.html" rel="external">ecallantide</a>, <a class="drug drug_general" data-topicid="118876" href="/d/drug information/118876.html" rel="external">lanadelumab</a>), preparations of C1INH concentrate (human), or plasma replacement (depending on the cause).</p><p class="headingAnchor" id="H11"><span class="h3">ACE inhibitors</span><span class="headingEndMark"> — </span>Angiotensin-converting enzyme (ACE) inhibitors account for approximately 30 percent of all angioedema cases presenting to emergency departments in both community and tertiary care settings [<a href="#rid8">8,9</a>]. ACE inhibitors impair degradation of multiple peptides, including bradykinin and substance P  (<a class="graphic graphic_figure graphicRef67838" href="/d/graphic/67838.html" rel="external">figure 1</a>). Angioedema related to ACE inhibitors most often affects the lips, tongue, mouth, larynx, pharynx, and subglottic tissues. Urticaria and itching are absent. ACE inhibitors can also cause intestinal edema, and the sudden onset of abdominal pain, nausea, and sometimes vomiting in an older adult should prompt inquiries about the use of ACE inhibitors. The epidemiology, pathophysiology, diagnosis, and management of patients with ACE inhibitor-induced angioedema is discussed separately. (See  <a class="medical medical_review" href="/d/html/16380.html" rel="external">"ACE inhibitor-induced angioedema"</a>.)</p><p>The risk of angioedema with the use of angiotensin II receptor blockers (ARBs), such as <a class="drug drug_general" data-topicid="9574" href="/d/drug information/9574.html" rel="external">losartan</a>, <a class="drug drug_general" data-topicid="10036" href="/d/drug information/10036.html" rel="external">valsartan</a>, and <a class="drug drug_general" data-topicid="10275" href="/d/drug information/10275.html" rel="external">telmisartan</a>, appears to be considerably lower than with ACE inhibitors [<a href="#rid10">10-12</a>]. The development of angioedema following therapy with ARBs is surprising since these drugs are not thought to affect kinin metabolism directly  (<a class="graphic graphic_figure graphicRef67838" href="/d/graphic/67838.html" rel="external">figure 1</a>). The administration of ARBs to a patient with past ACE inhibitor-induced angioedema is discussed separately. (See  <a class="medical medical_review" href="/d/html/16380.html" rel="external">"ACE inhibitor-induced angioedema"</a>.)</p><p>ACE inhibitors and ARBs may also unmask deficiencies of C1INH [<a href="#rid13">13-16</a>].</p><p class="headingAnchor" id="H3481319548"><span class="h4">DPP-4 inhibitors</span><span class="headingEndMark"> — </span>Dipeptidyl peptidase 4 (DPP-4) inhibitors (ie, gliptins) can also inhibit degradation of bradykinin and substance P and have been associated with an increased risk of angioedema, especially when used together with immunosuppressive drugs or ACE inhibitors [<a href="#rid17">17</a>]. (See  <a class="medical medical_review" href="/d/html/16380.html" rel="external">"ACE inhibitor-induced angioedema", section on 'Dipeptidyl peptidase-4 inhibitors'</a>.)</p><p class="headingAnchor" id="H13"><span class="h3">Hereditary and acquired angioedema due to C1 inhibitor deficiency</span><span class="headingEndMark"> — </span>Angioedema can occur in patients with abnormalities in the level or function of the regulatory serpin C1INH (previously referred to as C1 esterase inhibitor), leading to increased generation of bradykinin due to contact system (also known as plasma kallikrein-kinin system) activation. Angioedema in these disorders typically asymmetrically affects the face, lips, tongue, throat, ears, hands and feet, bowel wall, and genitalia and does not characteristically occur in dependent parts of the body. Clinical manifestations and diagnosis are reviewed in detail separately. (See  <a class="medical medical_review" href="/d/html/8103.html" rel="external">"Hereditary angioedema: Epidemiology, clinical manifestations, exacerbating factors, and prognosis"</a> and  <a class="medical medical_review" href="/d/html/8112.html" rel="external">"Acquired C1 inhibitor deficiency: Clinical manifestations, epidemiology, pathogenesis, and diagnosis"</a>.)</p><p>Summarized briefly, both hereditary and acquired forms of C1INH deficiency exist, with similar clinical manifestations. The main differences between the two conditions are the age of presentation and the underlying health of the patient:</p><p class="bulletIndent1"><span class="glyph">●</span>Patients with hereditary angioedema (HAE) typically present in childhood or early adolescence with angioedema, including recurrent abdominal attacks. Angioedema may follow trauma, infection, dental procedures, or emotional stress. There is typically an increasing frequency and severity of episodes with the onset of puberty. Exposure to estrogens, either through contraception, hormone replacement therapy, or pregnancy, may trigger attacks. These patients are otherwise healthy.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In contrast, the acquired form typically occurs at an older age, and most patients have an associated lymphoproliferative disorder or autoimmune diathesis. (See  <a class="medical medical_review" href="/d/html/8112.html" rel="external">"Acquired C1 inhibitor deficiency: Clinical manifestations, epidemiology, pathogenesis, and diagnosis", section on 'Associated disorders'</a>.)</p><p></p><p>The swelling with both forms of C1INH deficiency can range in severity during a given episode from a minor inconvenience to life-threatening laryngeal edema. Overall, there is a significant risk of morbidity and mortality from angioedema attacks.</p><p class="headingAnchor" id="H3210902853"><span class="h3">Hereditary angioedema with normal C1 inhibitor</span><span class="headingEndMark"> — </span>Familial angioedema with an autosomal dominant inheritance pattern but normal C1INH levels has been identified [<a href="#rid18">18</a>]. The clinical presentation of angioedema in these patients resembles but is subtlety different than HAE due to C1INH deficiency. (See  <a class="medical medical_review" href="/d/html/16529.html" rel="external">"Hereditary angioedema with normal C1 inhibitor"</a>.)</p><p>Specifically, these patients tend to be somewhat older at onset of swelling and have a greater ratio of orofacial swelling to abdominal swelling than HAE due to C1INH deficiency. Several subtypes of HAE with normal C1INH have been identified:</p><p class="bulletIndent1"><span class="glyph">●</span>HAE-FXII, defined by mutations involving coagulation factor XII</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>HAE-Plasminogen, defined by a mutation in the plasminogen gene</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>HAE-Angiopoietin-1, defined by a mutation in the angiopoietin-1 gene</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>HAE-Kininogen, defined by a mutation in the kininogen gene</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>HAE-Myoferlin, defined by a mutation in the myoferlin gene</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>HAE-HS3ST6, defined by a mutation in the heparan sulfate-glucosamine 3-O-sulfotransferase 6 gene</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>HAE-Unknown, which is the terminology used when patients meet the HAE with normal C1 inhibitor diagnostic criteria but have no recognized mutation</p><p></p><p class="headingAnchor" id="H593600599"><span class="h3">Fibrinolytic agents</span><span class="headingEndMark"> — </span>Angioedema without urticaria has been reported following fibrinolysis with streptokinase and <a class="drug drug_general" data-topicid="8478" href="/d/drug information/8478.html" rel="external">alteplase</a> in patients treated acutely for stroke and thrombosis [<a href="#rid19">19,20</a>]. The swelling associated with fibrinolytic agents is likely bradykinin mediated as plasmin has been reported to activate coagulation factor XII of the contact system [<a href="#rid21">21</a>]. This complication is discussed separately. (See  <a class="medical medical_review" href="/d/html/16134.html" rel="external">"Intravenous thrombolytic therapy for acute ischemic stroke: Therapeutic use", section on 'Angioedema'</a>.)</p><p class="headingAnchor" id="H15"><span class="h2">Etiologies of unknown mechanism</span><span class="headingEndMark"> — </span>There are several recognized causes of angioedema for which mechanisms are not defined  (<a class="graphic graphic_table graphicRef97087" href="/d/graphic/97087.html" rel="external">table 1</a>). The treatment of these disorders is reviewed separately. (See  <a class="medical medical_review" href="/d/html/8105.html" rel="external">"An overview of angioedema: Clinical features, diagnosis, and management"</a>.)</p><p class="headingAnchor" id="H16"><span class="h3">Idiopathic angioedema</span><span class="headingEndMark"> — </span>"Idiopathic angioedema" is the term applied to recurrent episodes of angioedema without urticaria for which no explanation can be found after a thorough evaluation to exclude allergic disorders, drug reactions, and defects in complement pathways. Idiopathic angioedema may be divided into idiopathic histaminergic angioedema and idiopathic nonhistaminergic angioedema. The diagnosis and management of idiopathic angioedema are presented separately. The former is often associated with chronic spontaneous urticaria or inducible forms of urticaria (ie, physical urticaria). Idiopathic histaminergic angioedema without hives may have distinct pathophysiology compared with chronic spontaneous urticaria with or without angioedema [<a href="#rid22">22</a>]. Idiopathic nonhistaminergic angioedema may represent new probands with HAE-Unknown because the penetrance of HAE with normal C1INH can be relatively low. (See  <a class="medical medical_review" href="/d/html/8105.html" rel="external">"An overview of angioedema: Clinical features, diagnosis, and management", section on 'Recurrent, idiopathic angioedema'</a>.)</p><p class="headingAnchor" id="H25098038"><span class="h3">Infections</span><span class="headingEndMark"> — </span>Infections have been associated with angioedema in children [<a href="#rid23">23</a>]. In a prospective study of 95 consecutive children with isolated angioedema (without urticaria or anaphylaxis) referred to an allergy clinic, angioedema was associated with infection in 19 (21 percent) [<a href="#rid24">24</a>]. Identified infections included the common cold (17 patients), streptococcal pharyngitis, and urinary tract infection. Infection was the most commonly associated disorder, followed by allergic etiologies. The association between angioedema and infections is not reported as regularly in adults. (See <a class="local">'Children'</a> below.)</p><p class="headingAnchor" id="H17"><span class="h3">Calcium channel blockers</span><span class="headingEndMark"> — </span>Both dihydropyridines (eg, <a class="drug drug_general" data-topicid="8627" href="/d/drug information/8627.html" rel="external">amlodipine</a>, <a class="drug drug_general" data-topicid="9700" href="/d/drug information/9700.html" rel="external">nifedipine</a>) and nondihydropyridines (eg, <a class="drug drug_general" data-topicid="9365" href="/d/drug information/9365.html" rel="external">diltiazem</a> and <a class="drug drug_general" data-topicid="10043" href="/d/drug information/10043.html" rel="external">verapamil</a>) have been associated with angioedema, either of the skin or small bowel [<a href="#rid25">25-29</a>]. However, no mechanism has been proposed.</p><p class="headingAnchor" id="H19"><span class="h3">Other drugs</span><span class="headingEndMark"> — </span>Other drugs that have been reported to cause angioedema without urticaria include <a class="drug drug_general" data-topicid="10329" href="/d/drug information/10329.html" rel="external">sirolimus</a>, <a class="drug drug_general" data-topicid="9078" href="/d/drug information/9078.html" rel="external">everolimus</a>, <a class="drug drug_general" data-topicid="8595" href="/d/drug information/8595.html" rel="external">amiodarone</a>, <a class="drug drug_general" data-topicid="9645" href="/d/drug information/9645.html" rel="external">metoprolol</a>, <a class="drug drug_general" data-topicid="9868" href="/d/drug information/9868.html" rel="external">risperidone</a>, <a class="drug drug_general" data-topicid="9743" href="/d/drug information/9743.html" rel="external">paroxetine</a>, and <a class="drug drug_general" data-topicid="8925" href="/d/drug information/8925.html" rel="external">etanercept</a> and other biologic agents [<a href="#rid30">30-38</a>]. Inhaled cocaine has been implicated in uvular angioedema [<a href="#rid39">39-42</a>].</p><p class="headingAnchor" id="H18165957"><span class="h3">Herbal medicines</span><span class="headingEndMark"> — </span>Several herbal medicines have been associated with angioedema, including garlic, sanyak, and <em>Ecballium elaterium</em> [<a href="#rid43">43-45</a>].</p><p class="headingAnchor" id="H20"><span class="h3">Other rare causes</span><span class="headingEndMark"> — </span>Other rare causes of angioedema include selected disorders with eosinophilia and urticarial vasculitis.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Disorders with eosinophilia</strong> – Angioedema is associated with a peripheral eosinophilia in two disorders, the hypereosinophilic syndromes (HES) and Gleich syndrome.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Approximately 15 percent of patients with the HES have angioedema, and this diagnosis should be considered in patients with dramatic elevations in peripheral eosinophil counts (eg, ≥1500 eosinophils/microliter) [<a href="#rid46">46,47</a>]. The mechanisms of the angioedema in this disorder may involve the direct release of vasodilatory mediators from eosinophils or may reflect the activation of cutaneous mast cells by eosinophil-derived mediators. (See  <a class="medical medical_review" href="/d/html/2211.html" rel="external">"Hypereosinophilic syndromes: Clinical manifestations, pathophysiology, and diagnosis"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>The entity of episodic angioedema with eosinophilia (Gleich syndrome) is characterized by recurrent episodes of angioedema, urticaria, pruritus, fever, weight gain, elevated serum immunoglobulin M (IgM), and leukocytosis with marked blood eosinophilia [<a href="#rid48">48-51</a>]. The level of blood eosinophilia parallels disease activity. The etiology of this syndrome is unknown but has been associated with upregulation of C5a receptors on eosinophils during episodes of disease [<a href="#rid52">52</a>]. Gleich syndrome is now considered a type of HES, although the absence of cardiac damage or other end-organ involvement and the episodic nature of the symptoms distinguish this condition from other forms of HES. (See  <a class="medical medical_review" href="/d/html/2211.html" rel="external">"Hypereosinophilic syndromes: Clinical manifestations, pathophysiology, and diagnosis", section on 'Episodic angioedema with eosinophilia (Gleich syndrome)'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Urticarial vasculitis</strong> – Angioedema may be observed in patients with hypocomplementemic urticarial vasculitis, in which immunoglobulin G (IgG) anti-C1q is often identified [<a href="#rid53">53,54</a>]. The urticarial lesions of urticarial vasculitis are variably painful, ecchymotic, and purpuric and often leave residual bruising upon resolution. Systemic disease and fever may be present. (See  <a class="medical medical_review" href="/d/html/8218.html" rel="external">"Urticarial vasculitis"</a>.)</p><p></p><p class="headingAnchor" id="H17189550"><span class="h1">CHILDREN</span><span class="headingEndMark"> — </span>There are very few studies of angioedema in children (other than hereditary angioedema [HAE]), and isolated angioedema (ie, without urticaria or anaphylaxis) appears to be uncommon in this age group. One study reported on 95 children referred to an allergy clinic and followed prospectively [<a href="#rid24">24</a>]. Most had more than one episode. In 51 percent, no cause could be identified. In the remaining one-half, the most common associations were common infections (21 percent), followed by various allergic disorders (14 percent), the presence of thyroid autoimmunity with normal thyroid function (8 percent), and nonsteroidal antiinflammatory drugs (NSAIDs; 6 percent). One-third of the children required ongoing treatment with antihistamines, and all improved with this intervention. (See <a class="local">'Infections'</a> above.)</p><p class="headingAnchor" id="H2044946052"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/108976.html" rel="external">"Society guideline links: Urticaria and angioedema (excluding hereditary angioedema)"</a>.)</p><p class="headingAnchor" id="H24227123"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)</p><p class="bulletIndent1"><span class="glyph">●</span>Basics topic (see  <a class="medical medical_basics" href="/d/html/17000.html" rel="external">"Patient education: Angioedema (The Basics)"</a> and  <a class="medical medical_basics" href="/d/html/121170.html" rel="external">"Patient education: Angioedema caused by ACE inhibitor medicines (The Basics)"</a>)</p><p></p><p class="headingAnchor" id="H21"><span class="h1">SUMMARY</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Definition and pathogenesis </strong>– Angioedema is self-limited, localized swelling of the skin or mucosal tissues. The presence of inflammatory mediators leads to a loss of vascular integrity, which allows fluid to move into the interstitial tissues. Angioedema may occur in isolation, accompanied by urticaria, or as a component of anaphylaxis. (See <a class="local">'Pathogenesis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Three groups of etiologies </strong>– The causes of angioedema can be divided into three groups based on the underlying mechanism  (<a class="graphic graphic_table graphicRef97087" href="/d/graphic/97087.html" rel="external">table 1</a>) (see <a class="local">'Causes'</a> above):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Mast cell mediated </strong>– Mast cell-mediated angioedema, such as that seen in allergic reactions and reactions to nonsteroidal antiinflammatory drugs (NSAIDs). (See <a class="local">'Mast cell-mediated etiologies'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Bradykinin mediated </strong>– Bradykinin-mediated angioedema, such as that induced by angiotensin-converting enzyme (ACE) inhibitors or hereditary or acquired C1 inhibitor (C1INH) deficiency. (See <a class="local">'Bradykinin-mediated etiologies'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Unknown mechanism </strong>– Causes with unknown mechanisms, such as idiopathic angioedema and angioedema associated with viral infections in children. (See <a class="local">'Etiologies of unknown mechanism'</a> above.)</p><p></p><p class="headingAnchor" id="H974723528"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>The editorial staff at UpToDate acknowledge Clifton O Bingham, III, MD, who contributed to earlier versions of this topic review.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Lin RY, Cannon AG, Teitel AD. Pattern of hospitalizations for angioedema in New York between 1990 and 2003. Ann Allergy Asthma Immunol 2005; 95:159.</a></li><li><a class="nounderline abstract_t">Commins SP, Satinover SM, Hosen J, et al. Delayed anaphylaxis, angioedema, or urticaria after consumption of red meat in patients with IgE antibodies specific for galactose-alpha-1,3-galactose. J Allergy Clin Immunol 2009; 123:426.</a></li><li><a class="nounderline abstract_t">Romano A, Viola M, Guéant-Rodriguez RM, et al. Imipenem in patients with immediate hypersensitivity to penicillins. N Engl J Med 2006; 354:2835.</a></li><li><a class="nounderline abstract_t">Zembowicz A, Mastalerz L, Setkowicz M, et al. Safety of cyclooxygenase 2 inhibitors and increased leukotriene synthesis in chronic idiopathic urticaria with sensitivity to nonsteroidal anti-inflammatory drugs. Arch Dermatol 2003; 139:1577.</a></li><li><a class="nounderline abstract_t">Fontaine C, Bousquet PJ, Demoly P. Anaphylactic shock caused by a selective allergy to celecoxib, with no allergy to rofecoxib or sulfamethoxazole. J Allergy Clin Immunol 2005; 115:633.</a></li><li><a class="nounderline abstract_t">Zuberbier T, Aberer W, Asero R, et al. The EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update. Allergy 2014; 69:868.</a></li><li><a class="nounderline abstract_t">Maurer M, Church MK, Marsland AM, et al. Questions and answers in chronic urticaria: where do we stand and where do we go? J Eur Acad Dermatol Venereol 2016; 30 Suppl 5:7.</a></li><li><a class="nounderline abstract_t">Agah R, Bandi V, Guntupalli KK. Angioedema: the role of ACE inhibitors and factors associated with poor clinical outcome. Intensive Care Med 1997; 23:793.</a></li><li><a class="nounderline abstract_t">Gandhi J, Jones R, Teubner D, Gabb G. Multicentre audit of ACE-inhibitor associated angioedema (MAAAA). Aust Fam Physician 2015; 44:579.</a></li><li><a class="nounderline abstract_t">ONTARGET Investigators, Yusuf S, Teo KK, et al. Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med 2008; 358:1547.</a></li><li><a class="nounderline abstract_t">van Rijnsoever EW, Kwee-Zuiderwijk WJ, Feenstra J. Angioneurotic edema attributed to the use of losartan. Arch Intern Med 1998; 158:2063.</a></li><li><a class="nounderline abstract_t">Abdi R, Dong VM, Lee CJ, Ntoso KA. Angiotensin II receptor blocker-associated angioedema: on the heels of ACE inhibitor angioedema. Pharmacotherapy 2002; 22:1173.</a></li><li><a class="nounderline abstract_t">Israili ZH, Hall WD. Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy. A review of the literature and pathophysiology. Ann Intern Med 1992; 117:234.</a></li><li><a class="nounderline abstract_t">Dykewicz MS. Cough and angioedema from angiotensin-converting enzyme inhibitors: new insights into mechanisms and management. Curr Opin Allergy Clin Immunol 2004; 4:267.</a></li><li><a class="nounderline abstract_t">Berkun Y, Shalit M. Hereditary angioedema first apparent in the ninth decade during treatment with ACE inhibitor. Ann Allergy Asthma Immunol 2001; 87:138.</a></li><li><a class="nounderline abstract_t">Ricketti AJ, Cleri DJ, Ramos-Bonner LS, Vernaleo JR. Hereditary angioedema presenting in late middle age after angiotensin-converting enzyme inhibitor treatment. Ann Allergy Asthma Immunol 2007; 98:397.</a></li><li><a class="nounderline abstract_t">Byrd JB, Woodard-Grice A, Stone E, et al. Association of angiotensin-converting enzyme inhibitor-associated angioedema with transplant and immunosuppressant use. Allergy 2010; 65:1381.</a></li><li><a class="nounderline abstract_t">Bork K, Barnstedt SE, Koch P, Traupe H. Hereditary angioedema with normal C1-inhibitor activity in women. Lancet 2000; 356:213.</a></li><li><a class="nounderline abstract_t">Ottomeyer C, Hennerici MG, Szabo K. Raising awareness of orolingual angioedema as a complication of thrombolysis in acute stroke patients. Cerebrovasc Dis 2009; 27:307.</a></li><li><a class="nounderline abstract_t">Walls RM, Pollack CV Jr. Successful cricothyrotomy after thrombolytic therapy for acute myocardial infarction: a report of two cases. Ann Emerg Med 2000; 35:188.</a></li><li><a class="nounderline abstract_t">Agostoni A, Gardinali M, Frangi D, et al. Activation of complement and kinin systems after thrombolytic therapy in patients with acute myocardial infarction. A comparison between streptokinase and recombinant tissue-type plasminogen activator. Circulation 1994; 90:2666.</a></li><li><a class="nounderline abstract_t">Sabaté-Brescó M, Rodriguez-Garijo N, Azofra J, et al. A Comparative Study of Sex Distribution, Autoimmunity, Blood, and Inflammatory Parameters in Chronic Spontaneous Urticaria with Angioedema and Chronic Histaminergic Angioedema. J Allergy Clin Immunol Pract 2021; 9:2284.</a></li><li><a class="nounderline abstract_t">Pattanaik D, Lieberman JA. Pediatric Angioedema. Curr Allergy Asthma Rep 2017; 17:60.</a></li><li><a class="nounderline abstract_t">Ertoy Karagol HI, Yilmaz O, Bakirtas A, et al. Angioedema without urticaria in childhood. Pediatr Allergy Immunol 2013; 24:685.</a></li><li><a class="nounderline abstract_t">Turcu AF, White JA, Kulaga ME, et al. Calcium channel blocker-associated small bowel angioedema. J Clin Gastroenterol 2009; 43:338.</a></li><li><a class="nounderline abstract_t">Southward J, Irvine E, Rabinovich M. Probable amlodipine-induced angioedema. Ann Pharmacother 2009; 43:772.</a></li><li><a class="nounderline abstract_t">Hedner T, Samuelsson O, Lindholm L, et al. Precipitation of angioedema by antihypertensive drugs. J Hypertens Suppl 1991; 9:S360.</a></li><li><a class="nounderline abstract_t">Romano A, Pietrantonio F, Garcovich A, et al. Delayed hypersensitivity to diltiazem in two patients. Ann Allergy 1992; 69:31.</a></li><li><a class="nounderline abstract_t">Sadick NS, Katz AS, Schreiber TL. Angioedema from calcium channel blockers. J Am Acad Dermatol 1989; 21:132.</a></li><li><a class="nounderline abstract_t">Er F, Nia AM, Erdmann E. [67-year-old patient with speech disorder and dysphagia]. Dtsch Med Wochenschr 2008; 133:2463.</a></li><li><a class="nounderline abstract_t">Fuchs U, Zittermann A, Berthold HK, et al. Immunosuppressive therapy with everolimus can be associated with potentially life-threatening lingual angioedema. Transplantation 2005; 79:981.</a></li><li><a class="nounderline abstract_t">Mackenzie M, Wood LA. Lingual angioedema associated with everolimus. Acta Oncol 2010; 49:107.</a></li><li><a class="nounderline abstract_t">Mahé E, Morelon E, Lechaton S, et al. Angioedema in renal transplant recipients on sirolimus. Dermatology 2007; 214:205.</a></li><li><a class="nounderline abstract_t">Burches E, Garcia-Verdegay F, Ferrer M, Pelaez A. Amiodarone-induced angioedema. Allergy 2000; 55:1199.</a></li><li><a class="nounderline abstract_t">Krikorian RK, Quick A, Tal A. Angioedema following the intravenous administration of metoprolol. Chest 1994; 106:1922.</a></li><li><a class="nounderline abstract_t">Sendur OF, Turan Y, Berkit IK, Tastaban E. Angio-oedema in a patient treated with etanercept for rheumatoid arthritis. Basic Clin Pharmacol Toxicol 2009; 104:488.</a></li><li><a class="nounderline abstract_t">Cooney C, Nagy A. Angio-oedema associated with risperidone. BMJ 1995; 311:1204.</a></li><li><a class="nounderline abstract_t">Kimyai-Asadi A, Harris JC, Nousari HC. Critical overview: adverse cutaneous reactions to psychotropic medications. J Clin Psychiatry 1999; 60:714.</a></li><li><a class="nounderline abstract_t">Kinsey CM, Howell M. A 27-year-old woman with a swollen uvula, chest pain, and elevated creatinine phosphokinase levels. Chest 2008; 133:809.</a></li><li><a class="nounderline abstract_t">Hidalgo Mora JJ, Giménez de Llano E, Sempere Verdú E, Feliú Sagalá M. [Uvular angioedema after intranasal cocaine consumption]. Med Clin (Barc) 2002; 119:438.</a></li><li><a class="nounderline abstract_t">Kestler A, Keyes L. Images in clinical medicine. Uvular angioedema (Quincke's disease). N Engl J Med 2003; 349:867.</a></li><li><a class="nounderline abstract_t">Welling A. Enlarged uvula (Quincke's Oedema)--a side effect of inhaled cocaine?--A case study and review of the literature. Int Emerg Nurs 2008; 16:207.</a></li><li><a class="nounderline abstract_t">Hur GY, Park HJ, Kim HA, et al. Identification of Dioscorea batatas (sanyak) allergen as an inhalant and oral allergen. J Korean Med Sci 2008; 23:72.</a></li><li><a class="nounderline abstract_t">Micozzi MS, Pribitkin EA. Common herbal remedies, adverse reactions, and dermatologic effects. Skinmed 2010; 8:30.</a></li><li><a class="nounderline abstract_t">Caiozzi G, Cabrera D, Mardónez JM, Saldías F. [Herbal medicines and severe adverse effects: uvular angioedema caused by Echballium elaterium]. Rev Med Chil 2002; 130:1407.</a></li><li><a class="nounderline abstract_t">Weller PF, Bubley GJ. The idiopathic hypereosinophilic syndrome. Blood 1994; 83:2759.</a></li><li><a class="nounderline abstract_t">Fauci AS, Harley JB, Roberts WC, et al. NIH conference. The idiopathic hypereosinophilic syndrome. Clinical, pathophysiologic, and therapeutic considerations. Ann Intern Med 1982; 97:78.</a></li><li><a class="nounderline abstract_t">Gleich GJ, Schroeter AL, Marcoux JP, et al. Episodic angioedema associated with eosinophilia. N Engl J Med 1984; 310:1621.</a></li><li><a class="nounderline abstract_t">Lassalle P, Gosset P, Gruart V, et al. Presence of antibodies against endothelial cells in the sera of patients with episodic angioedema and hypereosinophilia. Clin Exp Immunol 1990; 82:38.</a></li><li><a class="nounderline abstract_t">Bain BJ, Fletcher SH. Chronic eosinophilic leukemias and the myeloproliferative variant of the hypereosinophilic syndrome. Immunol Allergy Clin North Am 2007; 27:377.</a></li><li><a class="nounderline abstract_t">Florian S, Esterbauer H, Binder T, et al. Systemic mastocytosis (SM) associated with chronic eosinophilic leukemia (SM-CEL): detection of FIP1L1/PDGFRalpha, classification by WHO criteria, and response to therapy with imatinib. Leuk Res 2006; 30:1201.</a></li><li><a class="nounderline abstract_t">Nakashima K, Sakurada T, Imayama S, et al. A case of episodic angioedema associated with blood eosinophilia: upregulated C5a receptor expression on eosinophils. Allergy 1998; 53:320.</a></li><li><a class="nounderline abstract_t">Venzor J, Lee WL, Huston DP. Urticarial vasculitis. Clin Rev Allergy Immunol 2002; 23:201.</a></li><li><a class="nounderline abstract_t">Jara LJ, Navarro C, Medina G, et al. Hypocomplementemic urticarial vasculitis syndrome. Curr Rheumatol Rep 2009; 11:410.</a></li></ol></div><div id="topicVersionRevision">Topic 8099 Version 26.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16136766" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Pattern of hospitalizations for angioedema in New York between 1990 and 2003.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19070355" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Delayed anaphylaxis, angioedema, or urticaria after consumption of red meat in patients with IgE antibodies specific for galactose-alpha-1,3-galactose.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16807429" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Imipenem in patients with immediate hypersensitivity to penicillins.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14676074" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Safety of cyclooxygenase 2 inhibitors and increased leukotriene synthesis in chronic idiopathic urticaria with sensitivity to nonsteroidal anti-inflammatory drugs.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15753917" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Anaphylactic shock caused by a selective allergy to celecoxib, with no allergy to rofecoxib or sulfamethoxazole.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24785199" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : The EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27286498" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Questions and answers in chronic urticaria: where do we stand and where do we go?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9290997" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Angioedema: the role of ACE inhibitors and factors associated with poor clinical outcome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26510147" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Multicentre audit of ACE-inhibitor associated angioedema (MAAAA).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18378520" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Telmisartan, ramipril, or both in patients at high risk for vascular events.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9778207" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Angioneurotic edema attributed to the use of losartan.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12222553" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Angiotensin II receptor blocker-associated angioedema: on the heels of ACE inhibitor angioedema.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1616218" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy. A review of the literature and pathophysiology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15238791" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Cough and angioedema from angiotensin-converting enzyme inhibitors: new insights into mechanisms and management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11527246" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Hereditary angioedema first apparent in the ninth decade during treatment with ACE inhibitor.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17458439" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Hereditary angioedema presenting in late middle age after angiotensin-converting enzyme inhibitor treatment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20557296" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Association of angiotensin-converting enzyme inhibitor-associated angioedema with transplant and immunosuppressant use.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10963200" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Hereditary angioedema with normal C1-inhibitor activity in women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19208988" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Raising awareness of orolingual angioedema as a complication of thrombolysis in acute stroke patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10650237" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Successful cricothyrotomy after thrombolytic therapy for acute myocardial infarction: a report of two cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7994806" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Activation of complement and kinin systems after thrombolytic therapy in patients with acute myocardial infarction. A comparison between streptokinase and recombinant tissue-type plasminogen activator.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33831619" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : A Comparative Study of Sex Distribution, Autoimmunity, Blood, and Inflammatory Parameters in Chronic Spontaneous Urticaria with Angioedema and Chronic Histaminergic Angioedema.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28791569" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Pediatric Angioedema.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24028320" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Angioedema without urticaria in childhood.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19077729" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Calcium channel blocker-associated small bowel angioedema.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19299323" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Probable amlodipine-induced angioedema.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1687873" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Precipitation of angioedema by antihypertensive drugs.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1626756" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Delayed hypersensitivity to diltiazem in two patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2745759" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Angioedema from calcium channel blockers.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19006046" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : [67-year-old patient with speech disorder and dysphagia].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15849555" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Immunosuppressive therapy with everolimus can be associated with potentially life-threatening lingual angioedema.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20100146" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Lingual angioedema associated with everolimus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17377381" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Angioedema in renal transplant recipients on sirolimus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11117281" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Amiodarone-induced angioedema.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7988234" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Angioedema following the intravenous administration of metoprolol.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19371261" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Angio-oedema in a patient treated with etanercept for rheumatoid arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7488898" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Angio-oedema associated with risperidone.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10549695" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Critical overview: adverse cutaneous reactions to psychotropic medications.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18321910" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : A 27-year-old woman with a swollen uvula, chest pain, and elevated creatinine phosphokinase levels.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12381286" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : [Uvular angioedema after intranasal cocaine consumption].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12944572" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Images in clinical medicine. Uvular angioedema (Quincke's disease).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18627807" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Enlarged uvula (Quincke's Oedema)--a side effect of inhaled cocaine?--A case study and review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18303202" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Identification of Dioscorea batatas (sanyak) allergen as an inhalant and oral allergen.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20839422" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Common herbal remedies, adverse reactions, and dermatologic effects.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12611242" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : [Herbal medicines and severe adverse effects: uvular angioedema caused by Echballium elaterium].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8180373" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : The idiopathic hypereosinophilic syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7046556" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : NIH conference. The idiopathic hypereosinophilic syndrome. Clinical, pathophysiologic, and therapeutic considerations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6727934" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Episodic angioedema associated with eosinophilia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2208795" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Presence of antibodies against endothelial cells in the sera of patients with episodic angioedema and hypereosinophilia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17868855" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Chronic eosinophilic leukemias and the myeloproliferative variant of the hypereosinophilic syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16406018" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Systemic mastocytosis (SM) associated with chronic eosinophilic leukemia (SM-CEL): detection of FIP1L1/PDGFRalpha, classification by WHO criteria, and response to therapy with imatinib.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9542615" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : A case of episodic angioedema associated with blood eosinophilia: upregulated C5a receptor expression on eosinophils.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12221865" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Urticarial vasculitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19922730" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Hypocomplementemic urticarial vasculitis syndrome.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
